Michael C. Quirk serves as Executive at Sage Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Michael C. Quirk has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 31, 2025 involved selling 24,999 shares valued at $0.
Michael C. Quirk currently holds 0 shares of Sage Therapeutics, Inc. (SAGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael C. Quirk has been a net neutral trader of SAGE stock. They have purchased $0 and sold $0 worth of shares.
Michael C. Quirk's most recent insider trade was on Jul 31, 2025, when they sold 24,999 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |